4//SEC Filing
Ng George K 4
Accession 0000897069-25-001213
CIK 0001533743other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 4:25 PM ET
Size
5.6 KB
Accession
0000897069-25-001213
Insider Transaction Report
Form 4
Ng George K
DirectorChief Executive Officer
Transactions
- Award
Restricted Stock Units
2025-07-24+1,822,471→ 1,922,471 totalExercise: $0.00→ Common Stock (1,822,471 underlying)
Footnotes (2)
- [F1]Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,859,318 shares are subject to stockholder approval of the revised Omnibus Plan.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001638744
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 4:25 PM ET
- Size
- 5.6 KB